Related Experiment Video
Updated: Jun 21, 2026
09:08
From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Biosynthetic genes for aminoglycoside antibiotics
Fumitaka Kudo1, Tadashi Eguchi
1Department of Chemistry, Tokyo Institute of Technology, Meguro-ku, Tokyo, Japan.
The Journal of Antibiotics
|August 1, 2009
Summary
Researchers reanalyzed genes for 2-deoxystreptamine (2DOS)-containing aminoglycosides like kanamycin and gentamicin. This study aids in understanding the complex biosynthetic pathways of these crucial antibiotic classes.
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Significant advancements in aminoglycoside antibiotic biosynthesis research over the past decade.
- Identification of numerous biosynthetic gene clusters for various aminoglycoside antibiotics, including streptomycin, kanamycin, butirosin, neomycin, and gentamicin.
- Functional characterization of most butirosin and neomycin biosynthetic enzymes using recombinant proteins.
Purpose of the Study:
- To reanalyze the biosynthetic genes of 2-deoxystreptamine (2DOS)-containing aminoglycosides, focusing on kanamycin, gentamicin, and istamycin.
- To leverage genetic information and characterized enzymes from neomycin and butirosin pathways for this reanalysis.
- To propose enzymatic functions for uncharacterized enzymes involved in the biosynthesis of these related aminoglycosides.
Main Methods:
- Comparative analysis of genetic information from related aminoglycoside biosynthetic pathways.
- Utilizing characterized enzyme functions from neomycin and butirosin pathways.
- Reanalysis of biosynthetic genes for 2DOS-containing aminoglycosides.
Main Results:
- Proposed enzymatic functions for previously uncharacterized enzymes in the biosynthesis of kanamycin, gentamicin, and istamycin.
- A framework for understanding the genetic basis of structurally related 2DOS-containing aminoglycosides.
- Integration of existing knowledge from neomycin and butirosin pathways to elucidate complex biosynthetic routes.
Conclusions:
- The proposed enzymatic functions are crucial for advancing the study of complex aminoglycoside antibiotic biosynthetic pathways.
- This research provides a foundation for further investigation into the biosynthesis of important antibiotic classes.
- Facilitates a deeper understanding of the genetic regulation and enzymatic machinery behind 2DOS-containing aminoglycoside production.
More Related Videos
11:56Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:24Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
02:26tRNA Activation
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...